Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
AT ˙ WBAG ˙ US8816242098
30,30 € ↑0,90 (3,06%)
2026-06-05
DEL PRIS
SecurityAT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership142,344 shares
Latest Disclosed Value $ 4,287,401
IFP Advisors, Inc ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 142,344 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (AT:TEVA) valued at $3,601,303 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 138,271 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 2.95% during the quarter. The current value of the position is $4,184,914 USD.

IFP Advisors, Inc has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 142,344 4,073 2.95 4,287 -0.65 0.0889
2026-02-06 2025-12-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 138,271 137,580 19,910.27 4,315 33,092.31 0.0969
2026-02-06 2025-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS LTDSPONSORED ADS cs 881624209 691 -15 -2.12 14 18.18 0.0004
2025-12-02 2025-09-30 13F TEVA PHARMACEUTICAL INDS LTDSPONSORED ADS cs 881624209 691 -15 14 0.0004
2025-07-24 2025-06-30 13F TEV A PHARMACEUTICAL INDS cs 881624209 706 15 2.17 12 10.00 0.0003
2025-05-05 2025-03-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 691 -3,308 -82.72 11 -88.64 0.0003
2025-02-04 2024-12-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 3,999 1,960 96.13 88 144.44 0.0029
2025-02-04 2024-09-30 13F TEVA PHARMACEUTICAL INDS cs 881624209 2,039 1,898 1,346.10 37 1,700.00 0.0013
2024-07-30 2024-06-30 13F TEVA PHARMACEUTICAL INDS cs 881624209 141 0 0.00 2 100.00 0.0001
2024-07-30 2024-03-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 141 0 0.00 2 0.00 0.0001
2024-01-09 2023-12-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 141 -1,000 -87.64 1 -90.91 0.0001
2023-10-12 2023-09-30 13F TEVA PHARMACEUTICAL INDS cs 881624209 1,141 -707 -38.26 12 -15.38 0.0005
2023-08-14 2023-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS cs 881624209 1,848 611 49.39 14 -66.67 0.0006
2023-08-04 2023-06-30 13F TEVA PHARMACEUTICAL INDS cs 881624209 1,848 611 59 0.0027
2023-04-18 2023-03-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 1,237 368 42.35 40 0.0017
2023-02-07 2022-12-31 13F TEVA PHARMACEUTICAL INDS cs 881624209 869 -631 -42.07 0 -100.00 0.0007
2022-11-08 2022-09-30 13F TEVA PHARMACEUTICAL INDS cs 881624209 1,500 291 24.07 47 23.68 0.0012
2022-09-06 2022-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS cs 881624209 1,209 0 0.00 38 0.00 0.0012
2022-09-06 2022-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS cs 881624209 1,209 212 21.26 38 280.00 0.0012
2022-08-08 2022-03-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 997 0 32 0.0007
2022-01-12 2021-12-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 997 -32,820 -97.05 10 -97.00 0.0002
2021-10-06 2021-09-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 33,817 -15,305 -31.16 333 -30.91 0.0067
2021-07-13 2021-06-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 49,122 13,415 37.57 482 17.27 0.0100
2021-04-30 2021-03-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 35,707 7,000 24.38 411 47.84 0.0080
2021-01-25 2020-12-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 28,707 27,806 3,086.13 278 3,375.00 0.0113
2020-10-29 2020-09-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 901 -1,020 -53.10 8 -65.22 0.0005
2020-08-05 2020-06-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 1,921 -26,825 -93.32 23 -90.00 0.0018
2020-05-12 2020-03-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 28,746 28,145 4,683.03 230 4,500.00 0.0232
2020-01-17 2019-12-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 601 -15 -2.44 5 66.67 0.0004
2019-11-07 2019-09-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS Stock 881624209 616 486 373.85 3 50.00 0.0002
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDSLTD ADR Stock 881624209 130 -3,976 -96.83 2 -96.87 0.0003
2019-06-03 2018-12-31 13F/A-10 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 4,106 -2,916 -41.53 64 -57.62 0.0039
2019-01-23 2018-12-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 4,106 -2,916 64 0.0039
2019-06-03 2018-09-30 13F/A-9 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 7,022 -3,237 -31.55 151 -39.36 0.0062
2018-10-25 2018-09-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 7,022 -3,237 151 0.0062
2019-06-03 2018-06-30 13F/A-8 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 10,259 -529 -4.90 249 22.06 0.0105
2018-08-07 2018-06-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 10,259 -429 249
2019-06-03 2018-03-31 13F/A-7 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 10,788 0 0.00 204 0.00 0.0092
2018-05-09 2018-03-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 10,688 -100 183
2019-06-03 2017-12-31 13F/A-6 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 10,788 -2,959 -21.52 204 -15.70 0.0092
2018-01-24 2017-12-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 10,788 -2,959 204
2017-10-30 2017-09-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 13,747 1,118 8.85 242 -42.38 0.0096
2019-06-03 2017-06-30 13F/A-5 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 12,629 459 3.77 420 7.42 0.0178
2017-07-31 2017-06-30 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 12,629 459 420
2019-06-03 2017-03-31 13F/A-4 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 12,170 -1,379 -10.18 391 -20.37 0.0170
2017-04-26 2017-03-31 13F TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR ADR 881624209 12,170 -1,379 391
2019-06-03 2016-12-31 13F/A-3 TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 13,549 5,004 58.56 491 24.94 0.0237
2017-02-14 2016-12-31 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 13,549 5,004 491
2016-11-04 2016-09-30 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 8,545 -254 -2.89 393 -11.09 0.0204
2019-06-03 2016-06-30 13F/A-2 TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 8,799 8,669 6,668.46 442 22,000.00 0.0247
2016-08-22 2016-06-30 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 8,799 8,669 442
2019-06-03 2016-03-31 13F/A-1 TEVA PHARMACEUTICAL INDSLTD ADR Stock 881624209 130 -6,129 -97.92 2 -99.51 0.0003
2016-05-02 2016-03-31 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 8,549 2,290 457
2016-02-11 2015-12-31 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR 881624209 6,259 6,259 411 0.0276
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-06-03 2017-03-31 13F/A TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-06-03 2016-12-31 13F/A TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 1,700 -15.00 62 -32.61 n/a n/a n/a
2017-02-14 2016-12-31 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 1,700 62 n/a n/a n/a
2016-11-04 2016-09-30 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 2,000 33.33 92 22.67 n/a n/a n/a
2019-06-03 2016-06-30 13F/A TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 1,500 50.00 75 38.89 n/a n/a n/a
2016-08-22 2016-06-30 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 1,500 75 n/a n/a n/a
2016-05-02 2016-03-31 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 1,000 0.00 54 -18.18 n/a n/a n/a
2016-02-11 2015-12-31 13F TEVA PHARMACEUTICAL INDS LTD ADR ADR Call 1,000 66 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.